Allogenica

At Allogenica, we are transforming cell therapies for a healthier tomorrow. Our mission is to. We're developing a breakthrough cell therapy platform with the potential to: • : Providing less invasive, accessible alternatives for thousands of patients who currently have limited treatment options. • : With predictable safety and efficacy, we aim to make cell therapies available to a a broader patient population. • : By streamlining production, we aim to significantly lower the cost of cell therapies, making transformative treatments more accessible globally. Founded in 2022, Allogenica has rapidly emerged as a pioneer in the field. Our innovative approach includes: • : Enhancing compatibility with patients' immune systems, reducing the risk of rejection. • : Our platform has the potential to treat a diverse range of diseases, ensuring scalability and reaching more patients in need. • : Delivering affordable and faster-to-market therapies, to change lives on a global scale, potentially impacting millions. Allogenica is a preclinical-stage biotechnology company headquartered in Lyon, France!#CellTherapy #Biotech #HealthcareInnovation #CancerTreatment #RareDiseases #AutoimmuneDisorders #Lyon